Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xinda Pharmaceutical
Zibo, Shandong, China
- Ownership
- Private
- Employees
- ~160
- Development stage
- Other
01
Overview
Shandong Xinda Biotechnology is a leading GMP-compliant pharma excipient manufacturer in China, producing starch derivatives, cyclodextrins, cellulose, and magnesium stearate, with global export reach and collaborations with top Chinese academic institutions. The broader 'Xinda Pharmaceutical' term also encompasses Suzhou Xinda Biotechnology, which operates in biosimilars with a biosimilar ipilimumab program in late clinical development for oncology indications.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule excipientsBiologicsMonoclonal antibody
- Industry
- Biotech
Beyond the preview
Go deeper on Xinda Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xinda Pharmaceutical.